Identification Of Occupational Exposures In Patients With ILD
NCT04879082 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 150
Last updated 2021-05-10
Summary
Diffuse interstitial lung disease brings together a heterogeneous group of pulmonary pathologies, characterized by infiltrating and diffuse lesions of the pulmonary interstitium. The evolving risk of these ILD is pulmonary fibrosis, with the development of chronic respiratory failure.
The process of the etiological diagnosis of ILD results from a multidisciplinary approach (pulmonologists, radiologists, occupational health specialists, anatomo-pathologists, etc…). Indeed, the multitude of possible causes of these diseases makes the etiological diagnosis difficult. Professional aetiologies are also frequently mentioned : pneumoconiosis, hypersensitivity pneumonitis, as a differential diagnosis.
It therefore appears essential to deepen the professional aspect during the diagnostic process for ILD.
Since May 2020, a professional interview has been systematically offered by the Occupational Pathology Consultation Center of the Hospital Center Lyon Sud, to patients followed by the team of Professor Vincent COTTIN, whose file was discussed in a multidisciplinary meeting.
The data collected to constitute a database are the following variables: age, sex, diploma, professional course coded in CITP (International Standard Classification of Professions) and NAF (French Nomenclature of Activities), occupational exposures, smoking, risk factors non-professionals, clinical elements of ILD and elements relating to an occupational disease certificate. This database is anonymized.
Conditions
- Occupational Exposure
- Interstitial Lung Disease
Interventions
- OTHER
-
Professional course, occupational exposures
The data collected are the following variables: age, sex, diploma, professional course coded in CITP (International Standard Classification of Professions) and NAF (French Nomenclature of Activities), occupational exposures, smoking, risk factors non-professionals, clinical elements of ILD and elements relating to an occupational disease certificate. This database is anonymized. The precise diagnosis of ILD is retained during the multidisiciplinary meeting. Occupational exposures are assessed in specialized consultation : * a first professional interview phase: The professional history is traced, listing the training courses followed and the trades carried out. The questioning is precise and focuses on the different tasks performed, and the products used. * a second step, where a questionnaire is completed by the doctor: A list of specific substances is offered to the patient, who responds whether or not he thinks he has been exposed to them in his professional past.
Sponsors & Collaborators
-
Hospices Civils de Lyon
lead OTHER
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-05-15
- Primary Completion
- 2021-03-15
- Completion
- 2021-04-15
Countries
- France
Study Locations
More Related Trials
-
A Study of the Natural Progression of Interstitial Lung Disease (ILD)
NCT00470327 ·Status: RECRUITING
-
A Cohort of Patients With Phenotyped Diffuse Interstitial Lung Disease With Longitudinal Follow-up
NCT05810493 ·Status: RECRUITING
-
Interstitial Lung Disease Questionnaire
NCT01711151 ·Status: UNKNOWN
-
Non-interventional Study Describing Epidemiology, Prognosis and Patient Healthcare Costs in France, 2010-2017
NCT03858842 ·Status: UNKNOWN
-
Interpretation of the Role of Eosinophils in Diffuse Interstitial Pneumopathies
NCT06980844 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Idiopathic Pulmonary Fibrosis Job Exposures Study
NCT03211507 ·Status: COMPLETED
-
Dyspnea and Idiopathic Pulmonary Fibrosis
NCT04864990 ·Status: COMPLETED
-
Bronchoalveolar Lavage in Interstitial Lung Diseases to Characterization of Specific Inflammatory Cellular Infiltrate in Different Interstitial Lung Diseases
NCT07208201 ·Status: NOT_YET_RECRUITING
-
A Study to Characterize the Disease Behavior of Idiopathic Pulmonary Fibrosis (IPF) and Interstitial Lung Disease (ILD) During the Peri-Diagnostic Period
NCT03261037 ·Status: COMPLETED ·Phase: NA
-
Exploration of Metabolome in Patients With Interstitial Lung Disease and Pulmonary Hypertension With or Without Specific Pulmonary Hypertension Treatment
NCT07254338 ·Status: RECRUITING
-
Impulse Oscillometry for Prognostication in Idiopathic Pulmonary Fibrosis
NCT03898284 ·Status: COMPLETED
-
Advanced Mutidimensional and Ultra High Resolution Computed Tomography to Inspect Cardiopulmonary Involvement in Progressive Fibrosing Interstitial Lung Diseases
NCT06537934 ·Status: RECRUITING
-
Validation of Alveolar Probe-based Confocal Laser Endomicroscopy Descriptors in Diffuse Parenchymal Lung Diseases
NCT02961335 ·Status: TERMINATED ·Phase: NA
-
Functional MRI for Monitoring Progression and Assessing Trends in ILD
NCT07300696 ·Status: RECRUITING ·Phase: NA
-
PRospective Evaluation of Interstitial Lung DIsease Progression With Quantitative CT
NCT05609201 ·Status: ENROLLING_BY_INVITATION
-
Evaluation of HRCT Patterns in Systemic Sclerosis-associated Interstitial Lung Disease
NCT05482607 ·Status: RECRUITING
-
Novel Markers of Disease Progression in Interstitial Lung Disease
NCT05760508 ·Status: UNKNOWN
-
Families-At-risk for Interstitial Lung Disease Study
NCT03641742 ·Status: COMPLETED
-
Case-Control Study of Fibrotic Interstitial Lung Disease (ILD) and Cardiac Disease / Interventions.
NCT01154998 ·Status: UNKNOWN
-
Database for Interstitial Lung Disease
NCT04707781 ·Status: RECRUITING
-
Interstitial Lung Disease Exacerbations Study
NCT06685874 ·Status: ACTIVE_NOT_RECRUITING
-
Assessment of Peripheral Endothelial Function in Idiopathic Pulmonary Fibrosis
NCT02594059 ·Status: COMPLETED ·Phase: NA
-
Exhaled Breath Analysis Using eNose Technology as a Biomarker for Diagnosis and Disease Progression in Fibrotic ILD
NCT04680832 ·Status: ACTIVE_NOT_RECRUITING
-
Registry of Autoimmune Interstitial Lung Disease
NCT05365009 ·Status: RECRUITING
-
Inhalation Profiling of Idiopathic Pulmonary Fibrosis (IPF) Patients
NCT02058602 ·Status: COMPLETED ·Phase: PHASE1